KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Assets Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 0.83%
Dec 28, 2025 2.06%
Sep 28, 2025 3.26%
Jun 29, 2025 2.86%
Mar 30, 2025 2.78%
Dec 29, 2024 -0.35%
Sep 29, 2024 -0.18%
Jun 30, 2024 0.87%
Mar 31, 2024 -0.11%
Dec 31, 2023 -1.42%
Oct 1, 2023 -0.91%
Jul 2, 2023 6.57%
Apr 2, 2023 8.13%
Jan 1, 2023 5.91%
Oct 2, 2022 4.04%
Jul 3, 2022 4.64%
Apr 3, 2022 5.93%
Jan 2, 2022 5.97%
Oct 3, 2021 4.80%
Jul 4, 2021 4.33%
Apr 4, 2021 3.28%
Jan 3, 2021 3.60%
Sep 27, 2020 3.12%
Jun 28, 2020 1.20%
Mar 29, 2020 2.27%
Dec 29, 2019 3.76%
Sep 29, 2019 3.48%
Jun 30, 2019 3.52%
Mar 31, 2019 3.27%
Dec 30, 2018 4.66%
Sep 30, 2018 5.32%
Jul 1, 2018 5.57%
Apr 1, 2018 6.80%
Dec 31, 2017 6.46%
Oct 1, 2017 5.62%
Jul 2, 2017 4.17%
Apr 2, 2017 2.82%
Jan 1, 2017 2.10%
Oct 2, 2016 3.41%
Jul 3, 2016 3.99%
Apr 3, 2016 3.88%
Jan 3, 2016 3.21%
Sep 27, 2015 3.86%
Jun 28, 2015 4.49%
Mar 29, 2015 3.44%
Dec 28, 2014 4.68%
Sep 28, 2014 5.71%
Jun 29, 2014 6.44%
Mar 30, 2014 7.23%
Dec 29, 2013 8.84%
Sep 29, 2013 8.91%
Jun 30, 2013 10.44%
Mar 31, 2013 9.16%
Dec 30, 2012 8.62%
Sep 30, 2012 9.12%
Jul 1, 2012 9.80%